Literature DB >> 19203107

Current animal models: transgenic animal models for the study of measles pathogenesis.

C I Sellin1, B Horvat.   

Abstract

Animal models are highly important to understand the pathologic mechanisms of viral diseases. Therefore, the lack of a suitable animal model has greatly hindered the research into the pathogenesis of measles. Identification of two human receptors for measles virus, CD46 and CD150 (SLAM) has opened new perspectives in this field. During the last decade, numerous transgenic animal models have been developed in order to humanize mice and use them to study measles infection and virus-host interactions. Despite their limitations, these models have provided remarkable insights in different aspects of measles infection, providing a better understanding of virus-induced neuropathology, immunosuppression, mechanisms of virus virulence, and contribution of innate and adaptive immune response in viral clearance. They should certainly continue to help in studies of the host and viral factors that are important in measles infection and in developing of new antiviral agents and measles virus-based vaccines. In addition, as CD46 serves as a receptor for two other human viruses, some of these models may also find an important application in the study of adenovirus and herpesvirus 6 infection. In this review, we describe different CD46 and CD150 transgenic models and detail their utilization in the study of various aspects of measles pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19203107     DOI: 10.1007/978-3-540-70617-5_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  23 in total

1.  Virus-driven conditional expression of an interferon antagonist as a tool to circumvent host restriction.

Authors:  Denis Gerlier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

Review 2.  Interplay between innate immunity and negative-strand RNA viruses: towards a rational model.

Authors:  Denis Gerlier; Douglas S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2011-09       Impact factor: 11.056

3.  Sphingosine kinase 1 regulates measles virus replication.

Authors:  Madhuvanthi Vijayan; Young-Jin Seo; Curtis John Pritzl; Sarah Angela Squires; Stephen Alexander; Bumsuk Hahm
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

Review 4.  Measles virus-induced immunosuppression: from effectors to mechanisms.

Authors:  Elita Avota; Evelyn Gassert; Sibylle Schneider-Schaulies
Journal:  Med Microbiol Immunol       Date:  2010-04-08       Impact factor: 3.402

5.  An oncolytic measles virus-sensitive Group 3 medulloblastoma model in immune-competent mice.

Authors:  Sangeet Lal; Diego Carrera; Joanna J Phillips; William A Weiss; Corey Raffel
Journal:  Neuro Oncol       Date:  2018-11-12       Impact factor: 12.300

6.  Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides.

Authors:  C Mathieu; D Huey; E Jurgens; J C Welsch; I DeVito; A Talekar; B Horvat; S Niewiesk; A Moscona; M Porotto
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

7.  Measles virus neurovirulence and host immunity.

Authors:  Michael Oglesbee; Stefan Niewiesk
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

8.  Fatal measles virus infection prevented by brain-penetrant fusion inhibitors.

Authors:  Jeremy C Welsch; Aparna Talekar; Cyrille Mathieu; Antonello Pessi; Anne Moscona; Branka Horvat; Matteo Porotto
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

9.  Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150).

Authors:  Claudia S Antunes Ferreira; Marie Frenzke; Vincent H J Leonard; G Grant Welstead; Christopher D Richardson; Roberto Cattaneo
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

Review 10.  Towards a small animal model for hepatitis C.

Authors:  Alexander Ploss; Charles M Rice
Journal:  EMBO Rep       Date:  2009-10-16       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.